265 related articles for article (PubMed ID: 34771420)
1. Gallbladder Cancer: Current Insights in Genetic Alterations and Their Possible Therapeutic Implications.
Kuipers H; de Bitter TJJ; de Boer MT; van der Post RS; Nijkamp MW; de Reuver PR; Fehrmann RSN; Hoogwater FJH
Cancers (Basel); 2021 Oct; 13(21):. PubMed ID: 34771420
[TBL] [Abstract][Full Text] [Related]
2. Somatic genetic aberrations in gallbladder cancer: comparison between Chinese and US patients.
Yang P; Javle M; Pang F; Zhao W; Abdel-Wahab R; Chen X; Meric-Bernstam F; Chen H; Borad MJ; Liu Y; Zou C; Mu S; Xing Y; Wang K; Peng C; Che X
Hepatobiliary Surg Nutr; 2019 Dec; 8(6):604-614. PubMed ID: 31929987
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive clinicopathological and genomic profiling of gallbladder cancer reveals actionable targets in half of patients.
de Bitter TJJ; de Reuver PR; de Savornin Lohman EAJ; Kroeze LI; Vink-Börger ME; van Vliet S; Simmer F; von Rhein D; Jansen EAM; Verheij J; van Herpen CML; Nagtegaal ID; Ligtenberg MJL; van der Post RS
NPJ Precis Oncol; 2022 Nov; 6(1):83. PubMed ID: 36335173
[TBL] [Abstract][Full Text] [Related]
4. Identification of Altered Genes in Gallbladder Cancer as Potential Driver Mutations for Diagnostic and Prognostic Purposes: A Computational Approach.
D'Afonseca V; Arencibia AD; Echeverría-Vega A; Cerpa L; Cayún JP; Varela NM; Salazar M; Quiñones LA
Cancer Inform; 2020; 19():1176935120922154. PubMed ID: 32546937
[TBL] [Abstract][Full Text] [Related]
5. Analysis of DNA Damage Response Gene Alterations and Tumor Mutational Burden Across 17,486 Tubular Gastrointestinal Carcinomas: Implications for Therapy.
Parikh AR; He Y; Hong TS; Corcoran RB; Clark JW; Ryan DP; Zou L; Ting DT; Catenacci DV; Chao J; Fakih M; Klempner SJ; Ross JS; Frampton GM; Miller VA; Ali SM; Schrock AB
Oncologist; 2019 Oct; 24(10):1340-1347. PubMed ID: 31040255
[TBL] [Abstract][Full Text] [Related]
6. Precision oncology for gallbladder cancer: insights from genetic alterations and clinical practice.
Lin J; Dong K; Bai Y; Zhao S; Dong Y; Shi J; Shi W; Long J; Yang X; Wang D; Yang X; Zhao L; Hu K; Pan J; Sang X; Wang K; Zhao H
Ann Transl Med; 2019 Sep; 7(18):467. PubMed ID: 31700903
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive germline and somatic genomic profiles of Chinese patients with biliary tract cancer.
Yu H; Xu Y; Gao W; Li M; He J; Deng X; Xing W
Front Oncol; 2022; 12():930611. PubMed ID: 36072793
[TBL] [Abstract][Full Text] [Related]
8. ESMO recommendations on microsatellite instability testing for immunotherapy in cancer, and its relationship with PD-1/PD-L1 expression and tumour mutational burden: a systematic review-based approach.
Luchini C; Bibeau F; Ligtenberg MJL; Singh N; Nottegar A; Bosse T; Miller R; Riaz N; Douillard JY; Andre F; Scarpa A
Ann Oncol; 2019 Aug; 30(8):1232-1243. PubMed ID: 31056702
[TBL] [Abstract][Full Text] [Related]
9. Genomic profiling of gallbladder carcinoma: Targetable mutations and pathways involved.
Mishra S; Kumari S; Srivastava P; Pandey A; Shukla S; Husain N
Pathol Res Pract; 2022 Apr; 232():153806. PubMed ID: 35231860
[TBL] [Abstract][Full Text] [Related]
10. A next-generation sequencing-based strategy combining microsatellite instability and tumor mutation burden for comprehensive molecular diagnosis of advanced colorectal cancer.
Xiao J; Li W; Huang Y; Huang M; Li S; Zhai X; Zhao J; Gao C; Xie W; Qin H; Cai S; Bai Y; Lan P; Zou Y
BMC Cancer; 2021 Mar; 21(1):282. PubMed ID: 33726687
[TBL] [Abstract][Full Text] [Related]
11. Real-Time Targeted Genome Profile Analysis of Pancreatic Ductal Adenocarcinomas Identifies Genetic Alterations That Might Be Targeted With Existing Drugs or Used as Biomarkers.
Singhi AD; George B; Greenbowe JR; Chung J; Suh J; Maitra A; Klempner SJ; Hendifar A; Milind JM; Golan T; Brand RE; Zureikat AH; Roy S; Schrock AB; Miller VA; Ross JS; Ali SM; Bahary N
Gastroenterology; 2019 Jun; 156(8):2242-2253.e4. PubMed ID: 30836094
[TBL] [Abstract][Full Text] [Related]
12. Novel AMBRA1-ALK fusion identified by next-generation sequencing in advanced gallbladder cancer responds to crizotinib: a case report.
Zhou Y; Lizaso A; Mao X; Yang N; Zhang Y
Ann Transl Med; 2020 Sep; 8(17):1099. PubMed ID: 33145318
[TBL] [Abstract][Full Text] [Related]
13. Genomic Alterations of NTRK, POLE, ERBB2, and Microsatellite Instability Status in Chinese Patients with Colorectal Cancer.
Guo Y; Guo XL; Wang S; Chen X; Shi J; Wang J; Wang K; Klempner SJ; Wang W; Xiao M
Oncologist; 2020 Nov; 25(11):e1671-e1680. PubMed ID: 32627883
[TBL] [Abstract][Full Text] [Related]
14.
Uchida S; Sugino T
Curr Issues Mol Biol; 2023 Sep; 45(9):7404-7416. PubMed ID: 37754252
[TBL] [Abstract][Full Text] [Related]
15. Molecular profile of BRCA-mutated biliary tract cancers.
Spizzo G; Puccini A; Xiu J; Goldberg RM; Grothey A; Shields AF; Arora SP; Khushman M; Salem ME; Battaglin F; Baca Y; El-Deiry WS; Philip PA; Nassem M; Hall M; Marshall JL; Kocher F; Amann A; Wolf D; Korn WM; Lenz HJ; Seeber A
ESMO Open; 2020 Jun; 5(3):e000682. PubMed ID: 32576609
[TBL] [Abstract][Full Text] [Related]
16. Mutational frequency of
Sharma A; Kumar A; Kumari N; Krishnani N; Rastogi N
Ecancermedicalscience; 2017; 11():757. PubMed ID: 28900470
[TBL] [Abstract][Full Text] [Related]
17. Microsatellite instability status determined by next-generation sequencing and compared with PD-L1 and tumor mutational burden in 11,348 patients.
Vanderwalde A; Spetzler D; Xiao N; Gatalica Z; Marshall J
Cancer Med; 2018 Mar; 7(3):746-756. PubMed ID: 29436178
[TBL] [Abstract][Full Text] [Related]
18. Relationship between MLH1, PMS2, MSH2 and MSH6 gene-specific alterations and tumor mutational burden in 1057 microsatellite instability-high solid tumors.
Salem ME; Bodor JN; Puccini A; Xiu J; Goldberg RM; Grothey A; Korn WM; Shields AF; Worrilow WM; Kim ES; Lenz HJ; Marshall JL; Hall MJ
Int J Cancer; 2020 Nov; 147(10):2948-2956. PubMed ID: 32449172
[TBL] [Abstract][Full Text] [Related]
19. An Accurate and Comprehensive Clinical Sequencing Assay for Cancer Targeted and Immunotherapies.
Cao J; Chen L; Li H; Chen H; Yao J; Mu S; Liu W; Zhang P; Cheng Y; Liu B; Hu Z; Chen D; Kang H; Hu J; Wang A; Wang W; Yao M; Chrin G; Wang X; Zhao W; Li L; Xu L; Guo W; Jia J; Chen J; Wang K; Li G; Shi W
Oncologist; 2019 Dec; 24(12):e1294-e1302. PubMed ID: 31409745
[TBL] [Abstract][Full Text] [Related]
20. Molecular profiling of biliary cancers reveals distinct molecular alterations and potential therapeutic targets.
Weinberg BA; Xiu J; Lindberg MR; Shields AF; Hwang JJ; Poorman K; Salem ME; Pishvaian MJ; Holcombe RF; Marshall JL; Morse MA
J Gastrointest Oncol; 2019 Aug; 10(4):652-662. PubMed ID: 31392046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
